1. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection;M Bourlière;N Engl J Med,2017
2. Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial;X Forns;Lancet Infect Dis,2017
3. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. 2016. http://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf;jsessionid=C9A6E8F12C8AFB281EAEDC0C2ABA6EE9?sequence=1
4. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology &;GS Cooke;Hepatology Commission. Lancet Gastroenterol Hepatol,2019
5. REtrieval And cure of Chronic Hepatitis C (REACH): results of micro-elimination in the Utrecht province;PAM Kracht;Liver Int,2018